4.5 Article

State of the Art: Bridging to lung transplantation using artificial organ support technologies

期刊

JOURNAL OF HEART AND LUNG TRANSPLANTATION
卷 35, 期 12, 页码 1385-1398

出版社

ELSEVIER SCIENCE INC
DOI: 10.1016/j.healun.2016.10.005

关键词

lung transplantation; extracorporeal membrane oxygenation; mechanical ventilation; end-stage lung disease; artificial organ support

资金

  1. International Society for Heart and Lung Transplantation
  2. Deutsche Forschungsgemeinschaft
  3. German Center of Lung Research (DZL)
  4. Actelion Pharmaceuticals
  5. Bayer
  6. Gilead
  7. GSK
  8. MSD
  9. Pfizer

向作者/读者索取更多资源

Lung transplantation increasingly is being performed in recipients of higher risk and acuity. A subset of these patients has severely abnormal gas exchange and/or right ventricular dysfunction, such that artificial organ support strategies are required to bridge patients to lung transplantation. We review the rationales and currently used and potential strategies for bridging to lung transplantation and characterize bridging outcomes. Based on physiologic reasoning and a study of the existing literature, we provide a working strategy for bridging to lung transplantation. (C) 2016 International Society for Heart and Lung Transplantation. All rights reserved.

作者

我是这篇论文的作者
点击您的名字以认领此论文并将其添加到您的个人资料中。

评论

主要评分

4.5
评分不足

次要评分

新颖性
-
重要性
-
科学严谨性
-
评价这篇论文

推荐

暂无数据
暂无数据